Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics granted 324,622 stock options and 162,311 restricted stock units to a new employee under its 2019 Inducement Equity Incentive Plan. The awards were approved by the Compensation Committee on July 22, 2026, and granted on August 3, 2026, as an inducement material to the individual entering into employment.
Key figures
- Rsus granted
- 162311
- Options granted
- 324622
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.